Indian Company Master Data Made Simple
Parmax Pharma Limited
Profile data last updated: 19/12/2024
Founded in 1994, Parmax Pharma Limited has been operating for more than 31 years. Parmax Pharma Limited is registered with CIN L24231GJ1994PLC023504 (reg. no. 23504). It falls under the category of company limited by shares. The company has an authorized share capital of ₹6.00 crore. It has a paid-up capital totaling ₹3.74 crore.
Parmax Pharma Limited primarily operates in manufacture of chemicals and chemical products. It is incorporated within the Ahmedabad registry. Its official registered office is situated at Plot No. 20, Survey No. 52, Rajkot-gondal National Highway No. 27, Rajkot, Hadamtala, Gujarat, India, 360311. Currently, the company’s operational status is active. The Legal Entity Identifier assigned to the company is 335800838LWBPQU5MJ05. The designated company email address is [email protected]. Parmax Pharma Limited’s leading executives are Keyur Dineshbhai Vora (CFO).
Company Overview
- CIN
- Date of Incorporation
- 01/11/1994
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹6,00,00,000.00
- Paid up Capital
- ₹3,74,13,000.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹770.36L | ₹601.31L | ₹462.02L | ₹470.06L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,074.10L | ₹1,522.52L | ₹1,175.68L | ₹1,201.48L | ₹0.00L |
| Accumulated Depreciation | -₹971.57L | -₹1,059.51L | -₹888.34L | -₹700.48L | ₹0.00L |
| Tangible Book Value | -₹198.87L | ₹10.53L | ₹585.59L | ₹595.99L | ₹0.00L |
| Long Term Debt | ₹770.36L | ₹590.65L | ₹447.91L | ₹452.32L | ₹0.00L |
| Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹38.50L | ₹0.00L | ₹89.32L | ₹65.87L | ₹0.00L |
| Total Assets | ₹1,875.24L | ₹1,533.06L | ₹1,761.26L | ₹1,797.47L | ₹0.00L |
| Machinery Furniture Equipment | ₹1,385.46L | ₹1,572.68L | ₹1,433.00L | ₹1,351.98L | ₹0.00L |
| Total Equity Gross Minority Interest | -₹198.87L | ₹10.53L | ₹585.59L | ₹595.99L | ₹0.00L |
| Gross PPE | ₹1,768.91L | ₹1,997.08L | ₹1,838.39L | ₹1,744.75L | ₹0.00L |
| Common Stock | ₹445.12L | ₹445.12L | ₹445.12L | ₹445.12L | ₹0.00L |
| Total Capitalization | ₹571.49L | ₹601.18L | ₹1,033.50L | ₹1,048.32L | ₹0.00L |
| Total Debt | ₹808.86L | ₹590.65L | ₹537.23L | ₹518.19L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Equity Interest | -₹643.98L | -₹434.58L | ₹140.47L | ₹150.88L | ₹0.00L |
| Capital Stock | ₹445.12L | ₹445.12L | ₹445.12L | ₹445.12L | ₹0.00L |
| Total Non Current Assets | ₹874.95L | ₹956.02L | ₹1,008.38L | ₹1,141.51L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹9.03L | ₹5.05L | ₹19.13L | ₹83.93L | ₹0.00L |
| Invested Capital | ₹609.99L | ₹601.18L | ₹1,122.81L | ₹1,114.19L | ₹0.00L |
| Net Tangible Assets | -₹198.87L | ₹10.53L | ₹585.59L | ₹595.99L | ₹0.00L |
| Cash And Cash Equivalents | ₹9.03L | ₹5.05L | ₹19.13L | ₹83.93L | ₹0.00L |
| Prepaid Assets | ₹135.90L | ₹18.39L | ₹1.11L | ₹31.72L | ₹0.00L |
| Stockholders Equity | -₹198.87L | ₹10.53L | ₹585.59L | ₹595.99L | ₹0.00L |
| Share Issued | ₹37.41L | ₹37.41L | ₹37.41L | ₹37.41L | ₹0.00L |
| Current Assets | ₹1,000.28L | ₹577.04L | ₹752.88L | ₹655.97L | ₹0.00L |
| Working Capital | -₹303.46L | -₹344.17L | ₹39.22L | -₹75.45L | ₹0.00L |
| Net Debt | ₹799.82L | ₹585.59L | ₹518.10L | ₹434.27L | ₹0.00L |
| Ordinary Shares Number | ₹37.41L | ₹37.41L | ₹37.41L | ₹37.41L | ₹0.00L |
| Current Debt | ₹38.50L | ₹0.00L | ₹89.32L | ₹65.87L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹770.36L | ₹590.65L | ₹447.91L | ₹452.32L | ₹0.00L |
| Current Liabilities | ₹1,303.75L | ₹921.21L | ₹713.66L | ₹731.42L | ₹0.00L |
| Retained Earnings | -₹643.98L | -₹434.58L | ₹140.47L | ₹150.88L | ₹0.00L |
| Net PPE | ₹797.35L | ₹937.57L | ₹950.05L | ₹1,044.27L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹10.41L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | ₹0.00L | ₹0.00L | ₹39.61L | ₹79.23L | ₹0.00L |
| Common Stock Equity | -₹198.87L | ₹10.53L | ₹585.59L | ₹595.99L | ₹0.00L |
| Inventory | ₹331.44L | ₹239.49L | ₹430.61L | ₹285.25L | ₹0.00L |
| Other Properties | ₹172.91L | ₹216.59L | ₹208.40L | ₹197.06L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | -₹26.18L | -₹35.58L | -₹64.75L | -₹169.22L | ₹0.00L |
| Financing Cash Flow | ₹139.71L | ₹142.74L | -₹4.42L | -₹91.00L | ₹0.00L |
| Free Cash Flow | -₹165.89L | -₹178.31L | -₹60.33L | -₹78.22L | ₹0.00L |
| Investing Cash Flow | -₹70.14L | -₹158.69L | -₹93.64L | -₹153.16L | ₹0.00L |
| End Cash Position | -₹21.08L | ₹5.10L | ₹40.68L | ₹105.43L | ₹0.00L |
| Capital Expenditure | -₹70.14L | -₹158.69L | -₹93.64L | -₹153.16L | ₹0.00L |
| Beginning Cash Position | ₹5.10L | ₹40.68L | ₹105.43L | ₹274.64L | ₹0.00L |
| Operating Cash Flow | -₹95.75L | -₹19.63L | ₹33.31L | ₹74.94L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹0.45L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Discontinuous Operations | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Basic EPS | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| EBITDA | -₹89.17L | -₹342.14L | ₹230.64L | ₹259.03L |
| Operating Revenue | ₹2,820.40L | ₹1,105.30L | ₹1,542.43L | ₹1,825.11L |
| Total Unusual Items | -₹107.20L | -₹43.11L | -₹39.61L | -₹40.12L |
| Total Expenses | ₹2,898.10L | ₹1,570.27L | ₹1,462.13L | ₹1,721.64L |
| Tax Effect Of Unusual Items | -₹13.48L | -₹12.93L | -₹11.88L | -₹12.04L |
| Total Unusual Items Excluding Goodwill | -₹107.20L | -₹43.11L | -₹39.61L | -₹40.12L |
| Interest Income Non Operating | ₹1.49L | ₹1.97L | ₹1.57L | ₹3.09L |
| Interest Expense Non Operating | ₹47.17L | ₹52.28L | ₹38.17L | ₹35.50L |
| Interest Income | ₹1.49L | ₹1.97L | ₹1.57L | ₹3.09L |
| General And Administrative Expense | ₹53.95L | ₹47.65L | ₹70.59L | ₹74.53L |
| Net Income From Continuing And Discontinued Operation | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Reconciled Depreciation | ₹103.17L | ₹171.17L | ₹187.86L | ₹193.21L |
| Net Income Continuous Operations | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Reconciled Cost Of Revenue | ₹2,373.62L | ₹1,019.57L | ₹883.38L | ₹1,053.38L |
| Net Income | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Operating Income | -₹77.70L | -₹464.97L | ₹80.30L | ₹103.48L |
| Diluted Average Shares | ₹37.39L | ₹37.41L | ₹37.17L | ₹37.41L |
| Selling And Marketing Expense | ₹42.11L | ₹17.50L | ₹13.04L | ₹17.68L |
| Total Other Finance Cost | ₹11.40L | ₹10.04L | ₹1.88L | ₹3.53L |
| Normalized Income | -₹115.68L | -₹544.87L | ₹17.32L | ₹42.24L |
| Net Non Operating Interest Income Expense | -₹57.08L | -₹60.34L | -₹38.48L | -₹35.94L |
| Gross Profit | ₹446.77L | ₹85.73L | ₹659.06L | ₹771.73L |
| EBIT | -₹192.34L | -₹513.31L | ₹42.79L | ₹65.83L |
| Diluted NIAvailto Com Stockholders | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Cost Of Revenue | ₹2,373.62L | ₹1,019.57L | ₹883.38L | ₹1,053.38L |
| Net Interest Income | -₹57.08L | -₹60.34L | -₹38.48L | -₹35.94L |
| Operating Expense | ₹524.47L | ₹550.70L | ₹578.75L | ₹668.26L |
| Normalized EBITDA | ₹18.02L | -₹299.03L | ₹270.26L | ₹299.16L |
| Net Income Common Stockholders | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Pretax Income | -₹239.51L | -₹565.59L | ₹4.61L | ₹30.33L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹96.06L | ₹65.15L | ₹83.63L | ₹92.20L |
| Total Revenue | ₹2,820.40L | ₹1,105.30L | ₹1,542.43L | ₹1,825.11L |
| Other Operating Expenses | ₹4.84L | ₹17.11L | ₹20.61L | ₹26.93L |
| Diluted EPS | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Interest Expense | ₹47.17L | ₹52.28L | ₹38.17L | ₹35.50L |
| Basic Average Shares | ₹37.39L | ₹37.41L | ₹37.17L | ₹37.41L |
| Tax Provision | -₹30.11L | ₹9.46L | ₹15.02L | ₹16.18L |
| Net Income Including Noncontrolling Interests | -₹209.40L | -₹575.05L | -₹10.41L | ₹14.15L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 02/01/2016 | Umang Alkesh Gosalia | 05153830 | Managing Director | View other directorships |
| 02/01/2016 | Keyur Dineshbhai Vora | *****6633Q | CFO | |
| 17/06/2018 | Ami Shah Rajeshbhai | 08158605 | Director | View other directorships |
| 25/04/2023 | Nikhil Sureshchandra Uchat | 08427983 | Director | View other directorships |
| 02/05/2024 | Bhakti Rameshbhai Aghera | *****7822A | Company Secretary |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/12/2024 | Form MGT-7-28112024 | - |
| 30/10/2024 | Form AOC-4(XBRL)-30102024_signed | - |
| 26/10/2024 | Form AOC-4(XBRL)-26102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Plot No. 20, Survey No. 52, Rajkot-gondal National Highway No. 27, Rajkot, Hadamtala, Gujarat, India, 360311
Frequently Asked Questions
What is the incorporation date of Parmax Pharma Limited?
The incorporation date of Parmax Pharma Limited is 01/11/1994.
What is the authorized share capital and paid-up capital of Parmax Pharma Limited?
The authorized share capital of Parmax Pharma Limited is ₹6,00,00,000.00. The paid-up capital is ₹3,74,13,000.00.
Who are the current board members & directors of Parmax Pharma Limited?
The current board member of Parmax Pharma Limited are:
- Umang Alkesh Gosalia
- Ami Shah Rajeshbhai
- Nikhil Sureshchandra Uchat
What is the registered address of Parmax Pharma Limited?
The registered address of Parmax Pharma Limited is Plot No. 20, Survey No. 52, Rajkot-gondal National Highway No. 27, Rajkot, Hadamtala, Gujarat, India, 360311.
What is the Corporate Identification Number of Parmax Pharma Limited?
The Corporate Identification Number of Parmax Pharma Limited is L24231GJ1994PLC023504.